Mediwelcome Healthcare Management & Technology (HKSE:02159) ROCE %: 26.68% (As of Dec. 2025)


HKSE:02159 Mediwelcome Healthcare Management & Technology Inc HKSE:02159
54 GF Score
Price HK$1.61
GF Value HK$0.69
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Mediwelcome Healthcare Management & Technology ROCE %?

Mediwelcome Healthcare Management & Technology HKSE:02159 -0.62% 54 ROCE % is 26.68% as of Dec. 2025. GuruFocus rates HKSE:02159 with a GF Score™ of 54/100 and a GF Value™ of HK$0.69 (Significantly Overvalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Mediwelcome Healthcare Management & Technology's annualized ROCE % for the quarter that ended in Dec. 2025 was 26.68%.

Mediwelcome Healthcare Management & Technology  (HKSE:02159) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Mediwelcome Healthcare Management & Technology ROCE % Related Terms

Mediwelcome Healthcare Management & Technology ROCE % Historical Data

* Premium members only.

The historical data trend for Mediwelcome Healthcare Management & Technology's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mediwelcome Healthcare Management & Technology ROCE % Chart

Mediwelcome Healthcare Management & Technology Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only 2.75 -32.71 -56.56 -43.63 9.23

Mediwelcome Healthcare Management & Technology Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -78.68 -38.97 -49.16 -9.57 26.68
HKSE:02159
54GF Score
Mediwelcome Healthcare Management & Technology Inc HKSE:02159
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mediwelcome Healthcare Management & Technology ROCE % Calculation

Mediwelcome Healthcare Management & Technology's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=9.302/( ( (207.222 - 124.967) + (210.436 - 91.235) )/ 2 )
=9.302/( (82.255+119.201)/ 2 )
=9.302/100.728
=9.23 %

Mediwelcome Healthcare Management & Technology's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=26.374/( ( (239.536 - 161.041) + (210.436 - 91.235) )/ 2 )
=26.374/( ( 78.495 + 119.201 )/ 2 )
=26.374/98.848
=26.68 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 26.68% mean?
Mediwelcome Healthcare Management & Technology (HKSE:02159) has a ROCE % of 26.68% as of Dec. 2025.
Is Mediwelcome Healthcare Management & Technology's ROCE % too high?
Mediwelcome Healthcare Management & Technology's current ROCE % is 26.68%. The Healthcare Providers & Services industry median ROCE % is 6.41. Mediwelcome Healthcare Management & Technology's value of 26.68% is 316.2% above this industry median. Overall, Mediwelcome Healthcare Management & Technology has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mediwelcome Healthcare Management & Technology's ROCE % compare to VEEV and BTSG?
Mediwelcome Healthcare Management & Technology's ROCE % of 26.68% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Mediwelcome Healthcare Management & Technology's value of 26.68% is 316.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 643 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mediwelcome Healthcare Management & Technology's current ROCE % of 26.68% is 316.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mediwelcome Healthcare Management & Technology's current ROCE % is 26.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mediwelcome Healthcare Management & Technology stock overvalued right now?
Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology (HKSE:02159) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.69, compared to a current price of HK$1.61 — trading 133.3% above its estimated fair value. The current ROCE % is 26.68% and 316.2% above the Healthcare Providers & Services industry median of 6.41. Mediwelcome Healthcare Management & Technology's overall GF Score™ is 54/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Mediwelcome Healthcare Management & Technology (HKSE:02159), the current ROCE % is 26.68% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mediwelcome Healthcare Management & Technology (HKSE:02159) Overvalued in 2026?

Based on GuruFocus' analysis, Mediwelcome Healthcare Management & Technology stock appears to be overvalued. The current stock price of HK$1.61 is trading 133.3% above its estimated GF Value™ of HK$0.69. GuruFocus considers Mediwelcome Healthcare Management & Technology to be Significantly Overvalued.

Key valuation signals for HKSE:02159:

  • ROCE %: 26.68%
  • GF Value™: HK$0.69 vs. price of HK$1.61 (133.3% above fair value)
  • GF Score™: 54/100 with 4 warning signs
  • Industry Position: 316.2% above the Healthcare Providers & Services median

No single metric tells the full story. See the HKSE:02159 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mediwelcome Healthcare Management & Technology Business Description

Address Wangjingdongyuan Zone 4, Wangjing East Park, 17th Floor, Block B, Greenland Center, Chaoyang District, Beijing, CHN, 100101
Mediwelcome Healthcare Management & Technology Inc is an investment holding company. The Group mainly provides medical conference services, patient education and screening services, and marketing and consulting services, in addition to providing integrated healthcare marketing solutions. Its products and services include Academic Conference Management System, Scientific Research Data Reporting System, the Health/Medical Media Matrix, patient management services, and marketing and consulting services. The Group has only one reportable segment, mainly operating its businesses in the PRC and earning revenue from the PRC.
54GF Score

Get the complete analysis for HKSE:02159

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.61
Price
HK$0.69
GF Value